GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » BioLife Solutions Inc (FRA:BJX1) » Definitions » EV-to-Revenue

BioLife Solutions (FRA:BJX1) EV-to-Revenue : 11.83 (As of Jun. 01, 2025)


View and export this data going back to 2015. Start your Free Trial

What is BioLife Solutions EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, BioLife Solutions's enterprise value is €860.11 Mil. BioLife Solutions's Revenue for the trailing twelve months (TTM) ended in Mar. 2025 was €72.74 Mil. Therefore, BioLife Solutions's EV-to-Revenue for today is 11.83.

The historical rank and industry rank for BioLife Solutions's EV-to-Revenue or its related term are showing as below:

FRA:BJX1' s EV-to-Revenue Range Over the Past 10 Years
Min: 2.5   Med: 11.06   Max: 33.46
Current: 12.32

During the past 13 years, the highest EV-to-Revenue of BioLife Solutions was 33.46. The lowest was 2.50. And the median was 11.06.

FRA:BJX1's EV-to-Revenue is ranked worse than
86.41% of 824 companies
in the Medical Devices & Instruments industry
Industry Median: 3.09 vs FRA:BJX1: 12.32

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2025-06-01), BioLife Solutions's stock price is €19.90. BioLife Solutions's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2025 was €1.57. Therefore, BioLife Solutions's PS Ratio for today is 12.68.


BioLife Solutions EV-to-Revenue Historical Data

The historical data trend for BioLife Solutions's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioLife Solutions EV-to-Revenue Chart

BioLife Solutions Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
EV-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 25.76 12.72 9.98 9.54 13.90

BioLife Solutions Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
EV-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 12.95 15.42 16.33 13.90 12.90

Competitive Comparison of BioLife Solutions's EV-to-Revenue

For the Medical Instruments & Supplies subindustry, BioLife Solutions's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


BioLife Solutions's EV-to-Revenue Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, BioLife Solutions's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where BioLife Solutions's EV-to-Revenue falls into.


;
;

BioLife Solutions EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

BioLife Solutions's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=860.111/72.736
=11.83

BioLife Solutions's current Enterprise Value is €860.11 Mil.
BioLife Solutions's Revenue for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was €72.74 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


BioLife Solutions  (FRA:BJX1) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

BioLife Solutions's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=19.90/1.569
=12.68

BioLife Solutions's share price for today is €19.90.
BioLife Solutions's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was €1.57.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


BioLife Solutions EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of BioLife Solutions's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


BioLife Solutions Business Description

Traded in Other Exchanges
Address
3303 Monte Villa Parkway, Suite 310, Bothell, WA, USA, 98021
BioLife Solutions Inc is a life sciences company that develops, manufactures, and markets bioproduction products and services that are designed to improve quality and de-risk biologic manufacturing, distribution, and transportation in the cell and gene therapy ("CGT") industry. The company provides solutions such as Cell Processing, Cold Chain, and Thawing. The company generates the majority of its revenue from Cell Processing through the biopreservation product "CryoStor". Geographically the company generates the majority of its revenue from the United States.

BioLife Solutions Headlines

No Headlines